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Abstract
Importance
The rapid uptake of mobile phones in low and middle-income countries over the past
decade has provided public health programs unprecedented access to patients. While pro-
grams have used text messages to improve medication adherence, there have been no
high-powered trials evaluating their impact on tuberculosis treatment outcomes.
Objective
To measure the impact of Zindagi SMS, a two-way SMS reminder system, on treatment
success of people with drug-sensitive tuberculosis.
Design
We conducted a two-arm, parallel design, effectiveness randomized controlled trial in Kara-
chi, Pakistan. Individual participants were randomized to either Zindagi SMS or the control
group. Zindagi SMS sent daily SMS reminders to participants and asked them to respond
through SMS or missed (unbilled) calls after taking their medication. Non-respondents
were sent up to three reminders a day.
Setting
Public and private sector tuberculosis clinics in Karachi, Pakistan.
Participants
Newly-diagnosed patients with smear or bacteriologically positive pulmonary tuberculosis
who were on treatment for less than two weeks; 15 years of age or older; reported having
access to a mobile phone; and intended to live in Karachi throughout treatment were eligi-
ble to participate. We enrolled 2,207 participants, with 1,110 randomized to Zindagi SMS
and 1,097 to the control group.
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Main Outcome
The primary outcome was clinically recorded treatment success based upon intention-to-
treat.
Results
We found no significant difference between the Zindagi SMS or control groups for treatment
success (719 or 83% vs. 903 or 83%, respectively, p = 0782). There was no significant pro-
gram effect on self-reported medication adherence reported during unannounced visits dur-
ing treatment.
Conclusion
In this large-scale randomized controlled effectiveness trial of SMS medication reminders
for tuberculosis treatment, we found no significant impact.
Trial Registration
The trial was registered with ClinicalTrials.gov, NCT01690754.
Introduction
Tuberculosis is the second-leading cause of death from infectious diseases globally, with nine
million people infected and 1.5 million deaths in 2013 [1]. Treatment for drug-sensitive tuber-
culosis lasts six to eight months and can result in difficult side effects. Failure to adhere to treat-
ment can result in continued transmission, the development of multidrug-resistant
tuberculosis, or death. TheWorld Health Organization recommends directly observed therapy
to promote adherence, where a pre-assigned treatment supporter watches each patient take
his/her daily medication. However, evidence for the effectiveness of this method is inconclusive
[2].
The rapid uptake of mobile phones in low- and middle-income countries has provided pub-
lic-health programs unprecedented access to patients. Mobile phone-based interventions to
improve medication adherence have been adopted for many diseases, with mixed results[3–6].
Most trials are inadequately designed, insufficiently powered, or are restricted to high-income
countries [3–6]. The most rigorous trials evaluating mobile phone-use for treatment compli-
ance in developing countries exist for adherence to antiretroviral therapy (ART) for people liv-
ing with Human ImmunodeficiencyVirus (HIV). Meta-analysis that combines two positive
trials in Kenya [7,8] and one null result from Cameroon [9] found an overall positive impact of
weekly Short Message Service (SMS, or text message) reminders [10–12]. A more recent study
of interactive automated voice reminders and pictorial messages in India, found no impact on
adherence to ART [13].
While there is considerable interest in the potential of mobile phone-based interventions to
improve tuberculosis treatment adherence, rigorous evidence on their impact is limited [14–
17]. Recently, a limited cluster randomized trial in China found that, while medicationmonitor
reminders led to improved drug compliance for tuberculosis patients, daily two-way SMS
reminders did not [18]. Our effectiveness trial gauged the impact of a two-way interactive SMS
medication reminder system (Zindagi SMS) on the treatment success of people with drug-sen-
sitive tuberculosis.
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Methods
Study Design and Participants
Participants were recruited into the randomized controlled trial through a large tertiary center
(the Indus Hospital), nine public facilities, and a network of private General Practitioner (GP)
clinics and private laboratories in Karachi.
To be eligible, participants had to be newly diagnosedwith smear or bacteriologicallyposi-
tive pulmonary tuberculosis; 15 years of age or older; report having access to a mobile phone;
and intend to live in Karachi throughout treatment. To allow Zindagi SMS to help establish
habits early, participants had to be on treatment for less than two weeks. To minimize spill-
overs, patients with another household member in the study were ineligible. Enrolment contin-
ued until the predetermined sample size was met.
Eligible participants were consented using an oral consent form, a copy of which was given
to the participant. Oral consent was solicited instead of written consent, as our sample was a
low-literate population. The trial and oral consent procedure was approved by the research eth-
ics boards at Interactive Research and Development (IRD) in Karachi, Pakistan and the Massa-
chusetts Institute of Technology (MIT) in Cambridge, USA. The trial was registered with
ClinicalTrials.gov, NCT01690754.
Randomization and Masking
Once a patient consented to participate, a study representative entered identifying information
on a mobile phone-based enrolment form. Individual participants were randomized to either
the Zindagi SMS or control groups, using predetermined list on the study server that was gen-
erated using simple randomization. The research team was blinded to the allocation sequence
generated. If mobile data connectivity was interrupted (10% of enrolments), the study repre-
sentative called their supervisor, who entered the identifying information into Microsoft Excel
and generated the group assignment using the randomization function. In both cases field staff
who interacted directly with patients had no ability to influence the randomized allocation.
The randomization status of individual participants was not shared with treating clinics by the
research team.
Procedures
All study participants received the standard of care provided by their clinic. Initially, partici-
pants receivedNTP’s recommended eight-month treatment regimen. However, NTP guide-
lines changed in the second quarter of 2012 to a six-month regimen.
Zindagi SMS used two-way reminders to encourage patients to actively engage with remind-
ers, rather than passively read and potentially ignore them. It enabled the study team to identify
non-responsive patients for phone calls to encourage participation. Zindagi SMS sent enrolled
patients daily reminders at a time of their choosing.Messages were in Urdu using English
script and included a daily motivational message followed by a reminder to respond via SMS
or, after September 2011, a missed (unbilled) call to indicate they had taken their medication.
Fourteenmessages were randomized and sent to participants. Based on feedback from our
pilot, tuberculosis was not mentioned in the messages due to stigma [19]. For example, one
message said, “Your health is in your hands. Take your medication and remember to respond by
SMS or a missed call.” SMS responses were not verified for content. Participants were offered
PKR 60 (USD 0.60) per month to cover the costs of responding. Initially, the participants were
asked to pick up reimbursements at their clinic, but fromOctober 2013, reimbursements were
transferred directly to participants’ phones.
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Once Zindagi SMS received a response or a missed call, a confirmatory SMS message was
sent to the respondent. If the patient did not respond within two hours, a second reminder was
sent. A third and final reminder for the day was sent after two additional hours of non-respon-
siveness. Members of our study team phoned participants who did not respond for seven days.
Participants were interviewed at their household for a more extensive baseline. Ninety per-
cent of completed baseline surveys were conducted within 30 days of enrolment. Once a
month, study enumerators attempted surprise visits to participants’ households to conduct a
midline survey. Sputum samples, independent from those collected by the treating clinics, were
collected for patients at various points in their treatment. Given the difficulties in finding par-
ticipants at home and that they could not always produce sputum, there is considerable varia-
tion in the sputum samples available per patient. An endline surveywas conducted after the
completion of participants’ treatment period. Participants who were reported as having
defaulted or transferred out from treatment were surveyed again between September and
November 2014 to record whether they continued their treatment.
The enrolment form was entered on mobile phones, with paper forms as backup. Other sur-
veys were collected on paper and double-entered into a Microsoft Access database.
Outcomes
The primary outcome was programmatically defined treatment success as recorded in clinic
registers provided by the NTP, the global standard for assessing tuberculosis programs. Treat-
ment success is defined as the sum of patients clinically reported as cured (i.e. patient whose
sputum smear or culture was positive at the beginning of treatment but who was smear- or cul-
ture-negative in the last month of treatment and on at least one previous occasion) or treat-
ment completed (i.e. a patient who completed treatment but who does not have a negative
sputum smear or culture result in the last month or treatment and on at least one previous
occasion). In our secondary analysis, we explored the full range of clinically recorded treatment
outcomes (cured, treatment completed, default, died, treatment failure and transferred out). In
particular, Zindagi SMSmight have increased success by reducing default (i.e. a patient whose
treatment was interrupted for two consecutivemonths or more). The limitation of this out-
come is that because registers of NTP-reporting clinics in Pakistan are not linked, patients who
are reported as having default or transferred out could have continued treatment elsewhere. As
a robustness check we therefore explored adjusted treatment outcomes for treatment success
and default, substituting self-reported for clinically recorded outcomes for the participants
interviewed.
To explore potential mechanisms of impact (or lack of impact), we also gauged adherence
as a secondary outcome by asking participants whether they had taken their medication in the
last 24 hours during home visits. While self-reported adherence can be unreliable, there is no
reason to believemisreporting is systematically different among those assigned to Zindagi SMS
or the control group. During survey visits between February and April 2012, we conducted Iso-
Screen tests, which detect isoniazidmetabolites in urine samples to gauge whether tuberculosis
drugs were taken within the past 24 hours. Isoniazid is always included in first-line tuberculosis
treatment. We compared IsoScreen results with self-reported adherence on the same visit.
While IsoScreen tests were conducted on a non-random sample, they give us an indication of
the reliability of self-reported adherence.
Finally, we collected self-reported psychological and physical health measures as secondary
outcomes. We used a four-point Likert scale for patients’ difficulty in completing a range of
physical tasks and how supported they felt during treatment, a picture of a five-rung ladder
with six compartments between rungs for likelihoodof being cured, and images of five faces
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for how healthy they felt. Questions on participants’ ability to complete tasks and self-reported
health were asked at baseline, midline, and endline; the likelihood of being cured asked at base-
line and midline; and how supported participants felt asked at endline.
Statistical Analysis
We calculated a minimum sample size of 1,094 participants in each study arm, using power of
80%, minimum detectable effect size (MDE) of five percentage points, and treatment success
rate in the control group of 75%. An MDE of 5 percentage points was chosen because a smaller
impact was considered unlikely to motivate policy change. Data were analyzed using intention-
to-treat, i.e. allocation to treatment not actual take up. We used the χ2 test for differences in
proportions for the analysis of the primary outcome. In comparing sputum samples, we ran
ordinary least squares regressions, after controlling for days in the study and regimen type.
We also assessed whether Zindagi SMS had differential impacts on treatment success by
gender, indicators of quality of care, and mobile phone access. In analyzing our secondary out-
comes, we ran ordinary least squares regressions on each outcome to test for program effects,
after controlling for days since enrollment and regimen type. To adjust for multiple hypotheses
testing we used the Bonferroni correction and the less conservativeWestfall and Young free
step-down resampling method [20].
Statistical analysis was conducting using STATA/IC version 12.0. A p-value of<0.05 was
considered statistically significant.
Results
We enrolled 2,207 participants into the study betweenMarch 18, 2011 and February 25, 2014
(Fig 1). Both groups had similar baseline characteristics (Table 1).
As an effectiveness trial we sought to replicate implementation conditions, as it would exist
at scale. The Zindagi SMS system sent reminders or received responses for 174,284 patient days
to participants during their estimated treatment duration (180 days for the six-month regimen
or 240 days for the eight-month regimen).With perfect implementation, reminders should
have been sent for a total of 220,560 patient days, suggesting the system was successfully imple-
mented for 79% of patient days. Missed reminders were due to system failures, administrative
shortfalls, or GPRS outages in the city mobile (14%); participants asking to leave the system or
dying (3%); participants opting out of receiving reminders at enrolment (2%); and participants
not knowing their phone number at enrolment and failing to share their number subsequently
(2%). Of the 1,069 participants who were sent messages, 912 (85%) responded at least once. Of
the participants that were on the system throughout their treatment, the mean response rate
(calculated as the number of responses received over the number of reminders sent per patient)
was 29%, ranging from 0 to 99%. Over the course of treatment, average response rates fell from
48% in the first two weeks to 24% (eight-month regimen) and 20% (six-month regimen) in the
last two weeks (See Fig 2).
There were no significant differences in treatment outcomes between participants in the
Zindagi SMS group and the control group (Table 2). As a robustness check, we substituted the
clinically recorded outcomes with self-reported outcomes for participants who defaulted or
transferred out of treatment that we were able to interview, or whose family members reported
the participant had died. Of the 283 participants that were reported as having defaulted or
transferred out, we interviewed130 (46%); 49 participants (17%) had died; 22 (8%) refused to
be interviewed; and we were unable to locate 82 (29%). Self-reported outcomes were catego-
rized using the criteria in Fig 3. When we adjusted treatment outcomes to reflect the self-
reported outcomes, the default rate reduced in both groups but there were still no significant
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differences in outcomes between the two groups (Table 2). We also examined independent
sputum samples between the groups. We collected 1191 sputum samples for participants (603
in the Zindagi SMS group and 588 in the control group). Of these, one hundred and ninety
samples were excluded because they were primarily saliva, rather than sputum (104 in the Zin-
dagi SMS group and 86 in the control group). There was no statistically significant difference
between sputum results for both groups (p = 0.762).
There was no significant program effect in subgroups for gender, any of the indicators relat-
ing to quality of care, or access to a mobile phone after adjusting for multiple subgroups using
the Bonferroni correction (adjusted p-value of 0.003 for 17 subgroups) or theWestfall and
Young free step-down resampling correction (Table 3). We also created a single index of
Fig 1. Trial Profile.
doi:10.1371/journal.pone.0162944.g001
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quality of care from relevant variables and another for mobile phone access to test for subgroup
effect but again found no significant treatment effects for subgroups. (S1 Appendix)
We compared the results of 159 IsoScreen tests with self-reported adherence during the
same study visit. IsoScreen tests indicated that 17% of those who said they had taken their
drugs in the past 24 hours had not, indicating over-reporting. However, these results were not
statistically different by treatment arm.
There were no significant program effects in self-reportedmedication adherence or any of
our other secondary outcomes, after adjusting for multiple hypotheses using the Bonferroni
correction (p-value of 0.001 for five hypotheses) or theWestfall and Young correction
(Table 4).
Discussion
We found no significant impact of SMS medication reminders on treatment success, other
treatment outcomes, self-reported adherence, or self-reported physical and psychological
health. There were no statistically significant impacts of reminders on treatment success within
a variety of subgroups after adjusting for multiple hypothesis testing.
With an attrition rate of less than 1%, similar across arms, on our primary outcome variable,
the results are very robust. The inclusion of participants from public clinics, private GP clinics,
laboratories, and a large philanthropic hospital contributes to its external validity.
A limitation of our trial was the lack of an objective adherencemeasure. Adherence was
self-reported, which, IsoScreen tests indicated, is an overestimate of actual adherence. How-
ever, even if participation in Zindagi SMS generated increased adherence, not reflected in self-
reports, it did not translate into improved treatment outcomes. In addition, IsoScreen tests (on
Table 1. Demographic characteristics of participants enrolled in the trial (2011–2014, Karachi, Paki-
stan).*
SMS Group (n = 1110) Control Group (n = 1097)
n (%) n(%)
Female 561 (51%) 518 (47%)
Age (mean/SD) † 33 (16) 33 (16)
Urdu is mother tongue 529 (48%) 549 (50%)
Clinic type
Indus Hospital 404 (36%) 385 (35%)
GP clinic/private‡ laboratory 190 (17%) 193 (18%)
Public tuberculosis clinic 516 (46%) 519 (47%)
6 Month treatment regimen 764 (69%) 777 (71%)
Assigned a treatment supporter 102 (10%) 106 (10%)
Own mobile phone 540 (49%) 565 (52%)
Schooling
No school 517 (49%) 475 (47%)
Primary (class 1–5) 108 (10%) 115 (11%)
Secondary (class 6–10) 325 (31%) 307 (30%)
Tertiary (above class 10) 77 (7%) 101 (10%)
Religious school 15 (1%) 16 (2%)
*There are 138 missing values for assigned a treatment supporter, 145 missing values for age; 146 missing
values for no school and religious school; and 151 missing values for primary, secondary, and tertiary.
†SD = standard deviation
‡GP = private general practitioner
doi:10.1371/journal.pone.0162944.t001
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a nonrandom sample) indicated that misreportingwas similar in the Zindagi SMS and control
groups.
Another potential limitation is that clinics could incorrectly record treatment outcomes to
meet expected success rates encouraged by the NTP. However, since clinics were blind to allo-
cation, there is no reason any misreportingwas systematically different between treatment
arms. Moreover, in our sub-study on participants reported as having defaulted or transferred
out, self-reported outcomes were similar in the intervention and control groups. Another
Fig 2. Response rates over time in treatment.
doi:10.1371/journal.pone.0162944.g002
Table 2. Clinically-recorded treatment success between Zindagi SMS and control groups (2011–2014, Karachi, Pakistan).
Clinically recorded treatment success Clinically recorded treatment success adjusted for self-
reported outcomes
Zindagi SMS Control Group Zindagi SMS Control Group
n % N % p-value n % n % p-value
Treatment success 917 83% 903 83% 0.782 923 84% 911 83% 0.871
Treatment complete 332 30% 325 30% 0.863 339 31% 333 30% 0.903
Cured 585 53% 578 53% 0.960 584 53% 578 53% 0.994
Default 108 10% 103 9% 0.775 74 7% 80 7% 0.572
Died 19 2% 19 2% 0.975 38 3% 29 3% 0.282
Treatment Failure 27 2% 29 3% 0.758 26 2% 29 3% 0.655
Transfer Out 33 3% 39 4% 0.446 43 4% 44 4% 0.875
Total 1104 1093 1104 1093
doi:10.1371/journal.pone.0162944.t002
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potential limitation is that our trial took place in Pakistan, which reports high treatment suc-
cess rates of 91% in 2012 [1]. Results may differ in countries reporting lower success rates.
Our results were similar to the findings of Liu and colleagues in China that two-way SMS
reminders had no impact on medication adherence for tuberculosis patients, though we are
able to rule out much smaller effects of SMS reminders [15]. Meta-analysis of studies on HIV
and SMS reminders show positive results on of weekly SMS reminders on adherence and clini-
cal outcomes (Finitsis et al 2014 [10], Mbuagbaw et al 2013 [11], Horvath et al 2012) [12].
These reviews draw mainly on three large high quality studies (Finitsis et al also include many
small poor quality studies and Horvath et al only includes Lester and colleagues’ [7] and Pop-
Eleches and colleagues’[8] trials) and conclude weekly reminders are more effective than daily
reminders. The three key studies are Mbuagbaw and colleagues, who test weekly SMS remind-
ers in Cameroon and find no impact [9] Pop-Eleches and colleagues who tested multiple ver-
sions of SMS reminders and only found only short messages sent weekly improve adherence
[8], and Lester and colleagues find a positive impact of weekly reminders in Kenya [7]. Impor-
tantly, in Lester and colleagues, participants also received off-site clinician follow-up if they
Fig 3. Criteria for determining self-reported outcomes.
doi:10.1371/journal.pone.0162944.g003
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reported a problem or did not respond to the SMS [7, 21]. Not included in the reviews is Shet
and colleagues who test weekly automated telephone reminders in India and find no significant
effect [13].
Table 3. Sub-group analysis using treatment success as the outcome (2011–2014, Karachi, Pakistan).
Zindagi SMS
Group
Control
Group
Zindagi SMS naive FWER‡- adjusted
Sub-group N % n % coefficient p-value* p-value
Sex
Male 438 80% 468 81% -0.012 0.618 0.999
Female 479 86% 435 84% 0.019 0.394 0.974
Quality of care
Indus Hospital 317 79% 301 78% 0.005 0.872 1
GP Clinic/Private Lab 180 95% 167 87% 0.082 0.006† 0.069
Public TB Clinic 420 82% 435 84% -0.023 0.331 0.954
Assigned a treatment supporter 89 87% 84 79% 0.080 0.124 0.698
Not assigned a treatment supporter 793 84% 768 84% -0.004 0.815 1
Reminded to take medication (with one month after enrolment) 355 82% 324 83% -0.011 0.689 1
Not reminded to take medication (within one month after enrolment) 436 87% 446 84% 0.022 0.318 0.953
Access to a mobile phone
Own mobile phone 450 84% 474 84% -0.005 0.806 1
Don’t own mobile phone 467 82% 429 81% 0.016 0.502 0.994
No schooling 416 81% 381 80% 0.004 0.875 1
Any schooling 461 88% 469 87% 0.006 0.758 1
At least one literate person in the household 753 85% 744 84% 0.008 0.629 0.999
No literate people in the household 129 80% 108 81% -0.016 0.736 1
Can send SMS (within month of enrolment) 263 88% 232 87% 0.014 0.624 0.999
Cannot send SMS (within first month of enrolment) 528 83% 538 82% 0.001 0.958 1
*Bonferroni correction p-value (with 17 subgroups): 0.003
†p<0.05
‡Family-wise error rate20
doi:10.1371/journal.pone.0162944.t003
Table 4. Secondary outcomes between the Zindagi SMS and control groups (2011–2014, Karachi Pakistan).
Took medication
in the last 24
hours†
Perceptions on likelihood of
being cured† (6 = very likely,
1 = not likely)
How healthy they felt†
(5 = very healthy,
1 = very unhealthy)
Ease of completing
tasks† (4 = no difficulty,
1 = lot of difficulty)
How much support was
received† (4 = lot of
support, 1 = no support)
Zindagi 0.002 -0.008 -0.012 -0.017 0.020
Naïve p-
value*
0.772 0.473 0.423 0.036‡ 0.521
FWER§
adjusted p-
value
0.89 0.89 0.89 0.162 0.89
N (surveys) 11,301 9,560 11,324 11,235 1658
N (patients) 2091 2068 2091 2088 1658
*Bonferroni correction p-value (with 5 hypotheses): 0.001
† Controlling for the length of the regimen, days in the study, and days in the study-squared.
‡p<0.05
§Family-wise error rate [20]
doi:10.1371/journal.pone.0162944.t004
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Our study indicates that SMS reminders have no impact on treatment outcomes for patients
with drug-sensitive tuberculosis. Participants could operate the system (85% responded at least
once), but this did not translate into changed outcomes. We hypothesize that SMS reminders,
intended to combat forgetfulness, did not address the underlying factors that contribute to
patients leaving treatment. The steady decline of and the low mean of the response rate (29%)
suggest that participants tired of daily reminders. It is possible that longer intervals between
messages or greater off-site support for remote patients as in the Lester trial might be effective
[7, 21–22]. SMS reminders could be more useful for reminding patients of clinic appointments;
other forms of appointment reminders (telephone calls, home visits, letters) have helped tuber-
culosis patients [23]. Finally, SMS reminders could be coupled with financial incentives to
motivate patients to stay on course with treatment, especially given the important externalities
to the community associated with a patient complying with their treatment regime. Our cur-
rent study was initially intended to have an arm with incentives for medication adherence, but
the technology to link SMS reminders with adherence had manufacturing challenges. Our
results suggest pessimism for SMS medication reminders on their own.
In conclusion, we found no impact of SMS reminders on treatment success in tuberculosis
patients in the highest-powered such randomized control trial to date.
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